Inventor · disambiguated record
Gene M. Dubowchik
Also filed as: DUBOWCHIK GENE M · DUBOWCHIK GENE MICHAEL
33 granted patents·8 pending applications·1,685 citations·filing 1993–2025
97Inventor score
Files withBRISTOL MYERS SQUIBB CO30BIOHAVEN THERAPEUTICS LTD5LUO GUANGLIN2PFIZER IRELAND PHARMACEUTICALS2CHATURVEDULA PRASAD V1
Top patents by PatentIndex Score
41 records- 0199US6214345B1Lysosomal enzyme-cleavable antitumor drug conjugatesBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Apr 10, 2001·1.3k cites·258 claims
- 0296US6759509B1Branched peptide linkersBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jul 6, 2004·217 cites·35 claims
- 0391US10266578B2Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 23, 2019·9 cites·30 claims
- 0491US8314117B2CGRP receptor antagonistsLUO GUANGLIN·Filed 2010·Granted Nov 20, 2012·23 cites·18 claims
- 0590US10752609B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 25, 2020·6 cites·10 claims
- 0689US8481546B2CGRP receptor antagonistCHATURVEDULA PRASAD V·Filed 2011·Granted Jul 9, 2013·17 cites·3 claims
- 0789US7754732B2Spirocyclic anti-migraine compoundsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 13, 2010·13 cites·32 claims
- 0888US7314883B2Anti-migraine treatmentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jan 1, 2008·12 cites·36 claims
- 0987US7842808B2Anti-migraine spirocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 30, 2010·13 cites·36 claims
- 1086US7772244B2Therapeutic agents for the treatment of migraineBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 10, 2010·12 cites·14 claims
- 1180US9718804B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 1, 2017·5 cites·6 claims
- 1280US7569578B2Heterocyclic anti-migraine agentsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 4, 2009·14 cites·31 claims
- 1379US12097242B2Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 24, 2024·0 cites·26 claims
- 1479US7244746B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 17, 2007·9 cites·16 claims
- 1579US7220862B2Calcitonin gene related peptide receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 22, 2007·11 cites·36 claims
- 1678US12097241B2Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 24, 2024·0 cites·17 claims
- 1778US6515005B2Substituted azole derivatives as inhibitors of corticotropin releasing factorBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 4, 2003·13 cites·21 claims
- 1877US6888004B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 3, 2005·7 cites·23 claims
- 1975US11364281B2Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 21, 2022·0 cites·2 claims
- 2074US11185570B2Method of treating cardiovascular disease and heart failure with modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 2172US6908931B2Tetrahydroisoquinoline derivatives as melatonin MT2 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jun 21, 2005·5 cites·8 claims
- 2271US7470680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·9 claims
- 2370US7238699B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 3, 2007·3 cites·18 claims
- 2470US7125990B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 24, 2006·3 cites·17 claims
- 2565US6239146B1Neurotrophic difluoroamide agentsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 29, 2001·2 cites·13 claims
- 2660US2024309114A1Bifunctional degraders of galactose-deficient immunoglobulinsBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2760US2024252674A1Agents for directed conjugation techniques and conjugated productsBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2859US2025108124A1Antibody drug conjugates using mates technology for delivering cytotoxic agentsBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2955US6818643B1Neurotrophic bicyclic diamidesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Nov 16, 2004·1 cites·7 claims
- 3053US11053258B2Pyrimidine carboxamides as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 6, 2021·0 cites·9 claims
- 3153US2024066028A1Compositions for improved delivery of cgrp inhibitorsPFIZER IRELAND PHARMACEUTICALS·Filed 2021·Application pending·0 cites
- 3251US12030868B2Prodrugs of CGRP antagonistsPFIZER IRELAND PHARMACEUTICALS·Filed 2019·Granted Jul 9, 2024·0 cites·20 claims
- 3350US10774086B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 15, 2020·0 cites·7 claims
- 3450US2013053570A1CGRP Receptor AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 3550US2024067651A1Prodrugs of myeloperoxidase inhibitorsBIOHAVEN THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 3648US2025228957A1Bifunctional degraders of galactose-deficient immunoglobulinsBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 3747US2004063735A1Calcitonin gene related peptide receptor antagonistsFiled 2003·Application pending·0 cites
- 3846US9809573B2Substituted pyridine derivatives useful as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 7, 2017·0 cites·3 claims
- 3943US8748429B2CGRP receptor antagonistsLUO GUANGLIN·Filed 2012·Granted Jun 10, 2014·0 cites·14 claims
- 4043US6096762ANeurotrophic difluoroamide agentsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Aug 1, 2000·4 cites·11 claims
- 4136US6228872B1Neurotrophic diamide and carbamate agentsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted May 8, 2001·3 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Gene M. Dubowchik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →